WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Hypromellose is a ophthalmic solution that is FDA approved for the treatment of dryness of the eye and prevent further irritation.. Common adverse reactions include eye pain, changes in vision..
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Relieves dryness of the eye.
Temporarily relieves discomfort due to minor irritations of the eye or from exposure to wind and sun.
As a protectant against further irritation.
Dosage
Put 1 or 2 drops in the affected eye(s) as needed.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Hypromellose in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Hypromellose in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding FDA-Labeled Use of Hypromellose in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Hypromellose in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Hypromellose in pediatric patients.
Contraindications
There is limited information regarding Hypromellose Contraindications in the drug label.
Warnings
For external use only.
Do not use if sealed bottle tip is broken or punctured.
If solution changes color or becomes cloudy, do not use.
When using this product
To avoid contamination, do not touch tip of container to any surface.
Replace cap after using.
Stop use and ask a physician
If you experience eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours, discontinue use and consult a doctor.
Precautions
Description
Adverse Reactions
Clinical Trials Experience
eye pain
changes in vision
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Hypromellose in the drug label.
Drug Interactions
There is limited information regarding Hypromellose Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Hypromellose in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Hypromellose in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Hypromellose during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Hypromellose with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Hypromellose with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Hypromellose with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Hypromellose with respect to specific gender populations.
Race
There is no FDA guidance on the use of Hypromellose with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Hypromellose in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Hypromellose in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Hypromellose in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Hypromellose in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Hypromellose Administration in the drug label.
Monitoring
There is limited information regarding Monitoring of Hypromellose in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Hypromellose in the drug label.
Overdosage
There is limited information regarding Chronic Overdose of Hypromellose in the drug label.
Pharmacology
There is limited information regarding Hypromellose Pharmacology in the drug label.